NEXENTIS TECHNOLOGIES INC. Payments of Stock Issuance Costs
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Payments of Stock Issuance Costs of $696.67 thousand for the 0-month period ending 2022-08-15, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2024-04-01
- NEXENTIS TECHNOLOGIES INC. payments of stock issuance costs for the quarter ending 2021-09-30 was $0.00.
- NEXENTIS TECHNOLOGIES INC. payments of stock issuance costs for fiscal 2020 was $1.50M.
| Period end | Payments of Stock Issuance Costs 0 month | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2022-08-15 | $696.67K 10-K · filed 2024-04-01 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.50M 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $1.50M 10-Q · filed 2022-08-15 | ||||
| 2020-12-31 | $1.50M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |